Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Volume XXXII, No. 17 - December 8, 2025

Labs Enter a Critical PAMA Reform Window

CEO SUMMARY: A reprieve of upcoming PAMA cuts to lab test reimbursement rates is official with an extension through Jan. 30, 2026. This, however, is not a lot of time and pressure is on the clinical laboratory industry to get the RESULTS Act passed to permanently reform PAMA. Lab industry advocates are urging individual diagnostic […]

To access this post, you must purchase The Dark Report.

Labs Enter a Critical PAMA Reform Window Read More »

Paper, the Cloud, and Lessons for Laboratories

Paper requisitions. Cloud-based data. These two concepts are on opposite ends of the spectrum in clinical labs and pathology practices. Paper is an old-school institution that some labs continue to use. How many draw stations still require patients to fill out a hardcopy form and then immediately place it in a basket for a phlebotomist

To access this post, you must purchase The Dark Report.

Paper, the Cloud, and Lessons for Laboratories Read More »

Labs Enter a Critical PAMA Reform Window

CEO SUMMARY: A reprieve of upcoming PAMA cuts to lab test reimbursement rates is official with an extension through Jan. 30, 2026. This, however, is not a lot of time and pressure is on the clinical laboratory industry to get the RESULTS Act passed to permanently reform PAMA. Lab industry advocates are urging individual diagnostic

To access this post, you must purchase The Dark Report.

Labs Enter a Critical PAMA Reform Window Read More »

Pathologists Take Images to the Cloud

CEO SUMMARY: Scaled-up operations, streamlined logistics, and potential cybersecurity benefits all present a valid argument for pathology practices to move their data to the cloud. Digital pathology in particular stands to gain from a cloud-based setup that allows remote viewing of cases and better integration of AI-related features. Despite the advantages, cloud adoption remains sluggish

To access this post, you must purchase The Dark Report.

Pathologists Take Images to the Cloud Read More »

Abbott Bets Hard on Cancer Diagnostics with New Deal

Abbott Laboratories’ deal to acquire Exact Sciences for $23 billion emphasizes the value that the in vitro diagnostics (IVD) manufacturer puts on cancer testing. Clinical laboratories involved with oncology should monitor the progress of this deal and whether other IVD companies pursue similar endeavors, said Larry Worden, principal at research and consulting firm IVD Logix.

To access this post, you must purchase The Dark Report.

Abbott Bets Hard on Cancer Diagnostics with New Deal Read More »

Insights on Innovative Tech and Running a Clinical Lab in 2026

CEO SUMMARY: William Morice II, MD, PhD, the CEO at Mayo Clinic Laboratories, discusses technology that intrigues him and the important steps clinical laboratory leaders can take to better steer revenue opportunities as they head into the new year. Morice also comments on AI’s growing role in the lab. EDITOR’S NOTE: William Morice II, MD,

To access this post, you must purchase The Dark Report.

Insights on Innovative Tech and Running a Clinical Lab in 2026 Read More »

How One Lab Eliminated Paper through Front-End IT

CEO SUMMARY: Paper-based test ordering processes and employees overwhelmed with too many software applications were creating bottlenecks and stress at Sonora Quest Laboratories. CIO Sonny Varadan undertook an effort to eliminate paper requisitions and streamline work apps, resulting in decreased order processing times and less full-time staff needed to solve workflow pileups. While the process

To access this post, you must purchase The Dark Report.

How One Lab Eliminated Paper through Front-End IT Read More »

Quest, Labcorp Tout Their Alzheimer’s Tests and Use of AI

Executives at Quest Diagnostics and Labcorp cheered strong revenue growth in the third quarter. Both companies noted excellent recent launches of Alzheimer’s disease tests. In addition, both companies reported they are leaning heavily into artificial intelligence (AI). Quest and Labcorp touted their entries into Alzheimer’s testing. Quest CEO James Davis said during an investors call,

To access this post, you must purchase The Dark Report.

Quest, Labcorp Tout Their Alzheimer’s Tests and Use of AI Read More »

December 8, 2025, Intelligence: Late-Breaking Lab News

For the next 46 months, a Georgia fraudster will stay behind bars after pleading guilty to charges he violated the Anti-Kickback Statute by arranging for medically unnecessary genetic tests. A judge sentenced Patrick C. Moore, Jr. on Dec. 2. Moore was also ordered to pay $7.2 million in restitution for his crimes. According to the

To access this post, you must purchase The Dark Report.

December 8, 2025, Intelligence: Late-Breaking Lab News Read More »

;